➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Express Scripts
Medtronic
Harvard Business School
McKesson

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FENFLURAMINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Fenfluramine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000313 Predictive Values of Serotonergic Alterations for Outcome - 2 Terminated VA Office of Research and Development Phase 1 1969-12-31 The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome.
NCT00000313 Predictive Values of Serotonergic Alterations for Outcome - 2 Terminated National Institute on Drug Abuse (NIDA) Phase 1 1969-12-31 The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome.
NCT00000314 M-CPP and Fenfluramine in Cocaine Addicts - 3 Completed VA Office of Research and Development Phase 2 1969-12-31 The purpose of this study is to evaluate predictive value of M-CPP and fenfluramine challenges for outcome.
NCT00000314 M-CPP and Fenfluramine in Cocaine Addicts - 3 Completed National Institute on Drug Abuse (NIDA) Phase 2 1969-12-31 The purpose of this study is to evaluate predictive value of M-CPP and fenfluramine challenges for outcome.
NCT00000506 Cardiovascular System in Obesity: Effect of Treatment Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 2 1983-05-01 To determine the long-term efficacy of the combination therapy of phentermine and fenfluramine in conjunction with diet, exercise, and behavior modification in the treatment of simple, moderate obesity.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Fenfluramine Hydrochloride

Condition Name

Condition Name for Fenfluramine Hydrochloride
Intervention Trials
Dravet Syndrome 6
Lennox Gastaut Syndrome 4
Obesity 2
Cocaine-Related Disorders 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Fenfluramine Hydrochloride
Intervention Trials
Syndrome 7
Epilepsies, Myoclonic 6
Lennox Gastaut Syndrome 4
Epilepsy 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Fenfluramine Hydrochloride

Trials by Country

Trials by Country for Fenfluramine Hydrochloride
Location Trials
United States 52
United Kingdom 3
Canada 3
France 3
Belgium 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Fenfluramine Hydrochloride
Location Trials
California 5
Georgia 4
Florida 4
Colorado 4
Massachusetts 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Fenfluramine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Fenfluramine Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 8
Phase 2 5
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Fenfluramine Hydrochloride
Clinical Trial Phase Trials
Recruiting 5
Completed 4
Not yet recruiting 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Fenfluramine Hydrochloride

Sponsor Name

Sponsor Name for Fenfluramine Hydrochloride
Sponsor Trials
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 8
Zogenix, Inc. 2
National Institute on Drug Abuse (NIDA) 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Fenfluramine Hydrochloride
Sponsor Trials
Industry 11
Other 8
NIH 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Express Scripts
Baxter
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.